| Identification | Back Directory | [Name]
GLYCINE, SODIUM SALT HYDRATE, 99 | [CAS]
207300-76-3 | [Synonyms]
GLYCINE, SODIUM SALT HYDRATE, 99
Glycine, sodium salt hydrate 99% | [Molecular Formula]
C2 H4 N Na O2 . x H2 O | [MDL Number]
MFCD00150683 | [MOL File]
207300-76-3.mol | [Molecular Weight]
97.05 |
| Chemical Properties | Back Directory | [Appearance]
white crystalline powder | [Melting point ]
197-201°C | [form ]
solid | [biological source]
synthetic (organic) | [Major Application]
peptide synthesis | [InChI]
1S/C2H5NO2.Na.H2O/c3-1-2(4)5;;/h1,3H2,(H,4,5);;1H2/q;+1;/p-1 | [InChIKey]
CIJQGPVMMRXSQW-UHFFFAOYSA-M | [SMILES]
[Na+].[H]O[H].NCC([O-])=O |
| Hazard Information | Back Directory | [Chemical Properties]
white crystalline powder | [Uses]
Glycine sodium salt hydrate has been used as a component of buffer for homogenization of whole muscle for protein extraction and in electrophoresis buffer. It has also been used as a neurotransmitter in immunohistochemical staining of Zebrafish spinal cord sections. | [General Description]
Glycine is synthesized from choline, threonine and serine. It serves as a precursor for porphyrins, purines, glutathione and creatine. | [reaction suitability]
reaction type: solution phase peptide synthesis | [Biochem/physiol Actions]
Glycine is essential for the regulation immune function, metabolism, growth and development. It modulates intracellular Ca2+ levels and cytokines production. A reduction in glycine levels is observed in obesity, type 2 diabetes (T2DM), and non-alcoholic fatty liver disease (NAFLDs). Glycine is degraded to serine by glycine serine hydroxymethyltransferase 1 in cytoplasm. |
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Website: |
https://www.sigmaaldrich.cn |
|